Authors
Qianrui Xu, Yinan Zhu, Xinyan Li, Yanyan Zhang, Xue Peng, Zhangyue Sun, Xiehui Deng, Xiangyun Zong
Published in
International journal of women's health. Volume 18. Pages 628026. Epub Nov 05, 2026.
Abstract
Immediate breast reconstruction (IBR) after mastectomy may influence survival in node-positive breast cancer, but its association with survival according to axillary tumor burden remains unclear. The lymph node ratio (LNR), defined as the number of positive lymph nodes divided by the total number examined, may complement conventional N staging in reflecting axillary nodal burden.
We conducted a population-based retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) database (2010-2017). Female patients with nonmetastatic, node-positive breast cancer who underwent mastectomy with or without IBR were included. Propensity score matching balanced baseline covariates. Interaction analyses tested effect modification by LNR on overall survival (OS) and breast cancer-specific survival (BCSS).
Among 14,376 patients (4,358 IBR; 10,018 mastectomy alone), 4050 matched pairs were analyzed. The interaction between surgical approach and LNR remained statistically significant after PSM for OS (p=0.0078) and BCSS (p=0.0415). Using data-derived cutoffs, IBR was associated with improved OS in patients with LNR ≤0.34 (HR 0.71, 95% CI 0.62-0.81), whereas no statistically significant OS advantage was observed in those with LNR >0.34 (HR 0.91, 95% CI 0.79-1.04). A similar pattern was observed for BCSS (LNR ≤0.18: HR 0.68, 95% CI 0.57-0.82; LNR >0.18: HR 0.91, 95% CI 0.80-1.03). LNR-based analyses suggested heterogeneity in the association between IBR and survival.
In this retrospective cohort, LNR significantly modified the association between IBR and survival in patients with node-positive breast cancer. The data-derived LNR thresholds should be considered exploratory and require external validation before clinical application.
PMID:
43005919
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0